BAKER HEART AND DIABETES INSTITUTE

πŸ‡¦πŸ‡ΊAustralia
Ownership
-
Established
1858-01-01
Employees
481
Market Cap
-
Website
http://www.bakeru.edu
Clinical Trials
Related News

Echo Acquisition Despite Geographic Separation by Replication of Human Movements (EAGER)

Not Applicable
Not yet recruiting
Conditions
Echocardiography
First Posted Date
2024-12-19
Last Posted Date
2024-12-19
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
50
Registration Number
NCT06742905
Locations
πŸ‡¦πŸ‡Ί

Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor

First Posted Date
2023-10-18
Last Posted Date
2024-08-12
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
168
Registration Number
NCT06088212
Locations
πŸ‡¦πŸ‡Ί

Menzies Institute for Medical Research, Hobart, Tasmania, Australia

Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment

First Posted Date
2022-09-28
Last Posted Date
2024-08-22
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
612
Registration Number
NCT05558605
Locations
πŸ‡¦πŸ‡Ί

Alice Springs Hospital, Alice Springs, Northern Territory, Australia

Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer

First Posted Date
2022-05-09
Last Posted Date
2024-08-22
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
748
Registration Number
NCT05366153
Locations
πŸ‡¦πŸ‡Ί

Tom Marwick, Hobart, Tasmania, Australia

πŸ‡¦πŸ‡Ί

Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

First Posted Date
2021-07-30
Last Posted Date
2024-08-22
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
820
Registration Number
NCT04983823
Locations
πŸ‡¦πŸ‡Ί

Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

Risk-guided Disease Management in Coronary Artery Disease

First Posted Date
2021-07-19
Last Posted Date
2024-08-22
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
270
Registration Number
NCT04966117
Locations
πŸ‡¦πŸ‡Ί

Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)

First Posted Date
2021-07-15
Last Posted Date
2024-08-22
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
840
Registration Number
NCT04962711
Locations
πŸ‡¦πŸ‡Ί

Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

Early Detection of Coronary Artery Disease by Polygenic and Metabolic Risk Scoring

First Posted Date
2020-10-27
Last Posted Date
2024-08-22
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
1059
Registration Number
NCT04604353
Locations
πŸ‡¦πŸ‡Ί

Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension

Not Applicable
Completed
Conditions
Hypertension
Interventions
Device: Renal Denervation
Other: Sham control
First Posted Date
2015-05-14
Last Posted Date
2023-09-14
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
105
Registration Number
NCT02444442
Locations
πŸ‡¦πŸ‡Ί

Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia

Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure Patients

First Posted Date
2014-09-12
Last Posted Date
2018-11-02
Lead Sponsor
Baker Heart and Diabetes Institute
Registration Number
NCT02238457
Β© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy